Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ilya M Rachman

CEO, Chair at Immix Biopharma, Inc. (IMMX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$2K
Total bought / sold$5K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 10SEC IMMXImmix Biopharma, Inc. Buy 7461,141,683 held (+0%) $6.67 $5K +41.8%
  • Buy

    CEO, Chair Ilya M Rachman bought $5K of IMMX at $6.67 — first open-market purchase in our records.